Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke

Thrift, Amanda G., Kim, Joosup, Douzmanian, Vatche, Gall, Seana L., Arabshahi, Simin, Loh, Michelle and Evans, Roger G. (2014) Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke. Stroke, 45 2: 539-544. doi:10.1161/STROKEAHA.113.003368

Author Thrift, Amanda G.
Kim, Joosup
Douzmanian, Vatche
Gall, Seana L.
Arabshahi, Simin
Loh, Michelle
Evans, Roger G.
Title Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke
Journal name Stroke   Check publisher's open access policy
ISSN 0039-2499
Publication date 2014
Sub-type Article (original research)
DOI 10.1161/STROKEAHA.113.003368
Open Access Status Not Open Access
Volume 45
Issue 2
Start page 539
End page 544
Total pages 6
Place of publication Philadelphia, PA, United States
Publisher Lippincott Williams & Wilkins
Language eng
Subject 2705 Cardiology and Cardiovascular Medicine
2728 Clinical Neurology
2902 Advanced and Specialised Nursing
Formatted abstract
Background and Purpose - When optimally managed, patients with stroke are less likely to have further vascular events. We aimed to identify factors associated with optimal use of secondary prevention therapies in long-term survivors of stroke.

Methods - We carefully documented discharge medications at baseline and self-reported use of medications at annual follow-up in the Northeast Melbourne Stroke Incidence Study (NEMESIS). We defined optimal medication use when patients reported taking (1) antihypertensive agents and (2) statin and antithrombotic agents (ischemic stroke only). Logistic regression was used to assess factors associated with optimal medication use between 2 and 10 years after stroke.

Results - We recruited 1241 patients with stroke. Optimal prescription at discharge from hospital was the most important factor associated with optimal medication use at each time point: odds ratio (OR), 32.2 (95% confidence interval [CI], 13.6-76.1) at 2 years; OR, 7.86 (95% CI, 4.48-13.8) at 5 years (425 of 505 survivors); OR, 6.04 (95% CI, 3.18-11.5) at 7 years (326 of 390 survivors); and OR, 2.62 (95% CI, 1.19-5.77) at 10 years (256 of 293 survivors). Associations were similar in men and women. The association between optimal prescription at discharge and optimal medication use at each time point was greater in those who were not disadvantaged, particularly women.

Conclusions - Prescription of medications at hospital discharge was the strongest predictor of ongoing medication use in survivors of stroke, even at 10 years after stroke. Ensuring that patients with stroke are discharged on optimal medications is likely to improve their long-term management, but further strategies might be required among those who are disadvantaged.
Keyword Epidemiology
Medication adherence
Risk factors
Secondary prevention
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Public Health Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 4 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 4 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 10 Nov 2015, 15:57:57 EST by Anthony Yeates on behalf of Scholarly Communication and Digitisation Service